Resumo

EROL, Sara et al. Neonatal abstinence syndrome due to prenatally citalopram exposure: A case report. Arch. argent. pediatr. [online]. 2017, vol.115, n.6, pp.e424-e427. ISSN 0325-0075.  http://dx.doi.org/10.5546/aap.2017.e424.

Neonatal abstinence syndrome (NAS) due to prenatally exposure to citalopram can develop during the first days of life even with low dose of drug exposure. Supportive management is the first choice but phenobarbital can be used in treatment of this syndrome. Breastfeeding should not be interrupted. These neonates should be followed both for NAS and neurodevelopmental outcome. In this article, we reported a newborn with NAS due to citalopram exposure with a lower dose than previously reported in the literature, during the last six months of pregnancy. Phenobarbital was used because of non-pharmacological treatment failure.

Palavras-chave : Neonatal abstinence syndrome; Citalopram; Phenobarbital.

        · resumo em Espanhol     · texto em Espanhol     · Inglês ( pdf ) | Espanhol ( pdf )